<DOC>
	<DOCNO>NCT00288574</DOCNO>
	<brief_summary>This study evaluate effectiveness fluoxetine versus placebo reduce rate relapse anorexia nervosa ( AN ) enhance psychosocial behavioral recovery people treat AN .</brief_summary>
	<brief_title>Fluoxetine Prevent Relapse Enhance Psychological Recovery Women With Anorexia Nervosa</brief_title>
	<detailed_description>Anorexia nervosa ( AN ) , type eat disorder , serious psychiatric illness characterize extreme loss appetite . People AN view overweight bring eat , even though dangerously thin . Signs disorder include unusual eating habit , avoid food meal , pick food eat small quantity , carefully weigh portion food . Some people AN fully recover single episode , fluctuate pattern weight gain relapse , others experience chronic course illness many year . Effective drug treat disorder lack . In addition , past research examine effect medication initial phase treatment , time AN patient may respond medication acute effect starvation . Fluoxetine selective serotonin reuptake inhibitor ( SSRI ) commonly use treat depression . This study evaluate effectiveness fluoxetine versus placebo reduce rate relapse AN enhance psychosocial behavioral recovery woman already treat AN . Participants double-blind study recruit immediately follow completion treatment program AN , maintain body mass index ( BMI ) least 19 kg/m2 two week . Upon study entry , participant randomly assign receive either fluoxetine placebo 12 month . Participants begin receive medication one week prior discharge hospital receive care AN . Medication dos increase target dose 60 mg per day , exceed 80 mg per day . Participants receive 50 session cognitive-behavioral therapy , last approximately 45 minute occur twice weekly first month follow discharge hospital . After first month , therapy session occur weekly Month 9 every week Month 12 . Participants also report study site meet psychiatrist week first month follow discharge every week remainder study . General medical status , evidence AN relapse , medication dose , side effect assess visit . Upon complete treatment , follow-up telephone call occur Months 15 21 , follow-up visit hold Months 18 24 . Psychopathology associate AN , include concern weight shape , depressive symptom , anxiety , obsessive behavior , assess .</detailed_description>
	<mesh_term>Anorexia Nervosa</mesh_term>
	<mesh_term>Feeding Eating Disorders</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<criteria>Meets DSMIV criterion anorexia nervosa ( except requirement amenorrhea ) Successfully complete treatment one study sit inpatient dayprogram set immediately prior study entry ( BMI remain least 19 kg/m2 two week ) Currently take medication occasional lorazepam zopiclone anxiety sleep disturbance Previous serious adverse reaction fluoxetine ( e.g. , allergy ) Currently risk suicide Any medical condition require treatment psychotropic medication ( except occasional use antianxiety medication ) Pregnant Any serious medical illness besides eat disorder History continuous illness ( low weight period remission return normal function 15 year )</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Depression</keyword>
</DOC>